Aligning incentives to fulfil the promise of personalised medicine
Lancet
.
2015 May 23;385(9982):2118-9.
doi: 10.1016/S0140-6736(15)60722-X.
Epub 2015 May 6.
Authors
Victor J Dzau
1
,
Geoffrey S Ginsburg
2
,
Karen Van Nuys
3
,
David Agus
4
,
Dana Goldman
5
Affiliations
1
Institute of Medicine, Washington, DC, USA. Electronic address: vdzau@nas.edu.
2
Duke Center for Applied Genomics and Precision Medicine, Durham, NC, USA.
3
Precision Health Economics, Los Angeles, CA, USA.
4
University of Southern California Keck School of Medicine and Viterbi School of Engineering, Beverly Hills, CA, USA.
5
University of Southern California Schaeffer Center for Health Policy and Economics, Los Angeles, CA, USA.
PMID:
25957453
PMCID:
PMC6481305
DOI:
10.1016/S0140-6736(15)60722-X
No abstract available
MeSH terms
Biomedical Research
Chronic Disease / prevention & control
Diffusion of Innovation
Health Policy
Humans
Motivation
Precision Medicine*
Risk Assessment
Grants and funding
P30 AG024968/AG/NIA NIH HHS/United States